GENXOVITE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 23 Oct 2025)
What this means for you
Registered since 02 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88242858
- Registration number
- 6070377
- Mark type
- Stylized text
- Filed
- 27 Dec 2018
- Published for opposition
- 21 May 2019
- Registered
- 02 Jun 2020
- Attorney of record
- Vernon P. Squires
Goods and services
- Class 005 — Pharmaceuticals: Regenerative biologic products, namely, human umbilical cord derived allografts for the repair and/or regeneration of damaged tissue for medical use; biological preparations in the nature of regenerative biologic tissue for the repair and/or regeneration of damaged tissue for medical use
Owner
- GenXovite, LLC, Cedar Rapids, IA, US
- GenXovite, LLC, Cedar Rapids, IA, US
- GenXovite, LLC, Cedar Rapids, IA, US
Prosecution history
- 23 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Jun 2025 — TEAS SECTION 8 & 15 RECEIVED
- 02 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 02 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 29 Apr 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Apr 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Apr 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Mar 2020 — USE AMENDMENT FILED
- 09 Apr 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Mar 2020 — TEAS STATEMENT OF USE RECEIVED
- 18 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jan 2020 — SOU EXTENSION 1 GRANTED
- 16 Jan 2020 — SOU EXTENSION 1 FILED